ATE309357T1 - Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen - Google Patents

Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen

Info

Publication number
ATE309357T1
ATE309357T1 AT01936990T AT01936990T ATE309357T1 AT E309357 T1 ATE309357 T1 AT E309357T1 AT 01936990 T AT01936990 T AT 01936990T AT 01936990 T AT01936990 T AT 01936990T AT E309357 T1 ATE309357 T1 AT E309357T1
Authority
AT
Austria
Prior art keywords
variable region
monoclonal antibody
antibody against
surface antigen
hbv
Prior art date
Application number
AT01936990T
Other languages
English (en)
Inventor
Jong Wook Lee
Heui Keun Kang
Jung Hyun Nam
Moo Young Song
Paldal-Ku Dong
Hyung Jin Moon
Tae Hun Song
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of ATE309357T1 publication Critical patent/ATE309357T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01936990T 2000-05-29 2001-05-28 Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen ATE309357T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0028938A KR100419555B1 (ko) 2000-05-29 2000-05-29 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
PCT/KR2001/000894 WO2001092529A1 (en) 2000-05-29 2001-05-28 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same

Publications (1)

Publication Number Publication Date
ATE309357T1 true ATE309357T1 (de) 2005-11-15

Family

ID=36686692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936990T ATE309357T1 (de) 2000-05-29 2001-05-28 Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen

Country Status (10)

Country Link
US (3) US6680053B2 (de)
EP (1) EP1297141B1 (de)
JP (1) JP4112972B2 (de)
KR (1) KR100419555B1 (de)
CN (1) CN100503828C (de)
AT (1) ATE309357T1 (de)
AU (1) AU6276301A (de)
DE (1) DE60114829T2 (de)
IL (2) IL153066A0 (de)
WO (1) WO2001092529A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100423614B1 (ko) * 2001-05-16 2004-03-22 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
US20090191213A9 (en) * 2003-07-02 2009-07-30 Novo Nordisk A/S Compositions and methods for regulating NK cell activity
BRPI0412138B8 (pt) 2003-07-02 2021-05-25 Innate Pharma método de selecionar um anticorpo monoclonal, método de selecionar um anticorpo monoclonal ou seu fragmento de ligação em antígeno, método de detectar a presença de células nk, e, método de purificar de uma amostra células nk
KR100789645B1 (ko) * 2004-04-14 2007-12-27 주식회사유한양행 Ｂ형 간염바이러스의 ｓ-표면항원을 인식하는 인간화 항체및 이의 제조방법
GB0411378D0 (en) * 2004-05-21 2004-06-23 Astrazeneca Ab Pharmaceutical compositions
CA2601417C (en) 2004-07-01 2018-10-30 Novo Nordisk A/S Human anti-kir antibodies
WO2006085141A2 (en) * 2004-08-13 2006-08-17 Migenix Inc. Compositions and methods for treating or preventing hepadnaviridae infection
JP5154949B2 (ja) 2005-01-06 2013-02-27 ノヴォ ノルディスク アー／エス ウイルス感染を治療するための組成物および方法
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
AU2008323811B8 (en) 2007-11-08 2014-09-18 Precision Biologics, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
US9753036B2 (en) 2014-04-29 2017-09-05 Edp Biotech Corporation Methods and compositions for screening and detecting biomarkers
BR112020017715A2 (pt) 2018-03-16 2020-12-29 Zoetis Services Llc Vacinas de peptídeo contra interleucina-31
CA3093539A1 (en) 2018-03-16 2019-09-19 Zoetis Services Llc Interleukin-31 monoclonal antibodies for veterinary use
KR102745118B1 (ko) 2018-07-05 2024-12-23 이디피 바이오테크 코퍼레이션 마커 검출용 키트 및 방법
TWI904261B (zh) 2020-10-19 2025-11-11 美商碩騰服務公司 犬及貓抑瘤素Ｍ受體β之抗體及其用途
CN112521492B (zh) * 2020-12-18 2022-05-20 杭州贤至生物科技有限公司 乙肝表面抗原单克隆抗体的制备
WO2022173967A1 (en) 2021-02-11 2022-08-18 Edp Biotech Corporation Kits and methods for detecting markers and determining the presence or risk of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61104796A (ja) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体の製造方法
US5565354A (en) * 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
DE4425115A1 (de) * 1994-07-15 1996-01-18 Boehringer Mannheim Gmbh Verfahren zur Modifizierung der Stabilität von Antikörpern
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
EP0993470B1 (de) * 1997-06-27 2005-05-11 bioMerieux B.V. Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene
KR100250832B1 (ko) 1997-07-02 2000-04-01 박호군 비형 간염 바이러스의 표면 항원 프리-에스1 에피토프를 인식하는 생쥐 단일클론항체의 가변 영역,이를 암호하는 유전자 및 그의 염기 서열
ES2207278T3 (es) * 1998-07-28 2004-05-16 Micromet Ag Heterominicuerpos.
KR100345467B1 (ko) * 1998-08-12 2002-12-26 주)녹십자 B형 간염바이러스의 표면항원 s에 대한 인간화 항체 및 이의제조방법
US6589534B1 (en) * 1999-09-30 2003-07-08 Yeda Research And Development Co., Ltd. Hepatitis B virus binding proteins and uses thereof

Also Published As

Publication number Publication date
EP1297141B1 (de) 2005-11-09
US20020061581A1 (en) 2002-05-23
US6924368B2 (en) 2005-08-02
EP1297141A1 (de) 2003-04-02
US6680053B2 (en) 2004-01-20
KR20010107418A (ko) 2001-12-07
US20040191259A1 (en) 2004-09-30
KR100419555B1 (ko) 2004-02-19
AU6276301A (en) 2001-12-11
CN1441844A (zh) 2003-09-10
DE60114829D1 (de) 2005-12-15
JP2003534802A (ja) 2003-11-25
DE60114829T2 (de) 2006-08-03
WO2001092529A1 (en) 2001-12-06
US20050249753A1 (en) 2005-11-10
US7112664B2 (en) 2006-09-26
JP4112972B2 (ja) 2008-07-02
EP1297141A4 (de) 2004-07-14
CN100503828C (zh) 2009-06-24
IL153066A (en) 2010-11-30
IL153066A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
ATE309357T1 (de) Variable region des monoklonalen antikörpers gegen das hbv s-oberflächenantigen und für diese kodierendes gen
DE69526339D1 (de) Monoklonale antikörper, die an den vorläufer des tumorabstossantigen mage-1 anbinden, rekombinantes mage-1, und von mage-1 abgebieteteimmunogene peptide
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
CY1108179T1 (el) Τροποποιημενος παραγοντας viii
DE69936105D1 (de) Menschliche tslp nukleinsäuren und polypeptide
DE60133287D1 (de) Tumorantigen
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
EP1423510A4 (de) Antikörperglykosylierungsvarianten mit erhöhter antikörperabhängiger zellulärer zytotoxizität
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
EP1634956A4 (de) Rekombinanter adeno-assoziierter virusvektor zur behandlung von morbus alzheimer
EA200702008A1 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
DK2006301T3 (da) Peptid-baseret immuniseringsterapi til behandling af atherosklerose
DE60234085D1 (de) Rekombinantes super-verbindungs-interferon zur verwendung als hepatitis b oberflächenatigen und e-antigen-inhibitor
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
DK1370284T3 (da) Bakteriofag-medieret immunisering
CY1107594T1 (el) DNA ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ IL-1η
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
ATE312846T1 (de) Monoklonale antikörper gegen hepatitis b virus
WO2005061539A3 (en) Treatment of viral infections
MXPA02004505A (es) Peptidos mimeticos para epitope de apolipoproteinab-100 concatamero y peptidos modificados del mismo, y la composicion de vacuna que comprende los mismos.
ATE240349T1 (de) Peptide zur inhibierung von hpv e6-proteinen
DK1276495T3 (da) Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
DK1545594T3 (da) Bakteriofag-medieret immunisering mod Hepatitis
DE60124299D1 (de) Peptide aus dem b-glycoprotein des menschlichen herpesvirus-7, besonders anwendbar bei serologischen elisa-nachweisen
CY1115966T1 (el) Ανταγωνιστικα αντισωματα anti-htnfsf13b ανθρωπου

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1297141

Country of ref document: EP

REN Ceased due to non-payment of the annual fee